AIMS: Detailed data on patients admitted for acute myocardial infarction (AMI) on a European-wide basis are lacking. The Euro Heart Survey 2009 Snapshot was designed to assess characteristics, management, and hospital outcomes of AMI patients throughout European Society of Cardiology (ESC) member countries in a contemporary 'real-world' setting, using a methodology designed to improve the representativeness of the survey. METHODS: Member countries of the ESC were invited to participate in a 1-week survey of all patients admitted for documented AMI in December 2009. Data on baseline characteristics, type of AMI, management, and complications were recorded using a dedicated electronic form. In addition, we used data collected during the same time period in national registries in Sweden, England, and Wales. Data were centralized at the European Heart House. RESULTS: Overall, 4236 patients (mean age 66±13 years; 31% women) were included in the study in 47 countries. Sixty per cent of patients had ST-segment elevation myocardial infarction, with 50% having primary percutaneous coronary intervention and 21% fibrinolysis. Aspirin and thienopyridines were used in >90%. Unfractionated and low-molecular-weight heparins were the most commonly used anticoagulants. Statins, beta-blockers, and angiotensin-converting enzyme inhibitors were used in >80% of the patients. In-hospital mortality was 6.2%. Regional differences were observed, both in terms of population characteristics, management, and outcomes. CONCLUSIONS: In-hospital mortality of patients admitted for AMI in Europe is low. Although regional variations exist in their presentation and management, differences are limited and have only moderate impact on early outcomes.
AIMS: Detailed data on patients admitted for acute myocardial infarction (AMI) on a European-wide basis are lacking. The Euro Heart Survey 2009 Snapshot was designed to assess characteristics, management, and hospital outcomes of AMI patients throughout European Society of Cardiology (ESC) member countries in a contemporary 'real-world' setting, using a methodology designed to improve the representativeness of the survey. METHODS: Member countries of the ESC were invited to participate in a 1-week survey of all patients admitted for documented AMI in December 2009. Data on baseline characteristics, type of AMI, management, and complications were recorded using a dedicated electronic form. In addition, we used data collected during the same time period in national registries in Sweden, England, and Wales. Data were centralized at the European Heart House. RESULTS: Overall, 4236 patients (mean age 66±13 years; 31% women) were included in the study in 47 countries. Sixty per cent of patients had ST-segment elevation myocardial infarction, with 50% having primary percutaneous coronary intervention and 21% fibrinolysis. Aspirin and thienopyridines were used in >90%. Unfractionated and low-molecular-weight heparins were the most commonly used anticoagulants. Statins, beta-blockers, and angiotensin-converting enzyme inhibitors were used in >80% of the patients. In-hospital mortality was 6.2%. Regional differences were observed, both in terms of population characteristics, management, and outcomes. CONCLUSIONS: In-hospital mortality of patients admitted for AMI in Europe is low. Although regional variations exist in their presentation and management, differences are limited and have only moderate impact on early outcomes.
Authors: Ph Gabriel Steg; Stefan K James; Dan Atar; Luigi P Badano; Carina Blömstrom-Lundqvist; Michael A Borger; Carlo Di Mario; Kenneth Dickstein; Gregory Ducrocq; Francisco Fernandez-Aviles; Anthony H Gershlick; Pantaleo Giannuzzi; Sigrun Halvorsen; Kurt Huber; Peter Juni; Adnan Kastrati; Juhani Knuuti; Mattie J Lenzen; Kenneth W Mahaffey; Marco Valgimigli; Arnoud van 't Hof; Petr Widimsky; Doron Zahger Journal: Eur Heart J Date: 2012-08-24 Impact factor: 29.983
Authors: Lori Mandelzweig; Alex Battler; Valentina Boyko; Hector Bueno; Nicolas Danchin; Gerasimos Filippatos; Anselm Gitt; David Hasdai; Yonathan Hasin; Jaume Marrugat; Frans Van de Werf; Lars Wallentin; Shlomo Behar Journal: Eur Heart J Date: 2006-08-14 Impact factor: 29.983
Authors: S Gottlieb; D Harpaz; A Shotan; V Boyko; J Leor; M Cohen; L Mandelzweig; B Mazouz; S Stern; S Behar Journal: Circulation Date: 2000-11-14 Impact factor: 29.690
Authors: Stefan Grajek; Maciej Lesiak; Aleksander Araszkiewicz; Małgorzata Pyda; Włodzimierz Skorupski; Marek Grygier; Przemysław Mitkowski; Marek Prech; Artur Baszko; Magdalena Janus; Piotr Breborowicz; Janusz Rzeźniczak; Janusz Tarchalski; Andrzej Główka; Andrzej Cieśliński Journal: Kardiol Pol Date: 2008-02 Impact factor: 3.108
Authors: Nicolas Danchin; Pierre Coste; Jean Ferrières; Philippe-Gabriel Steg; Yves Cottin; Didier Blanchard; Loïc Belle; Bernard Ritz; Gilbert Kirkorian; Michael Angioi; Philippe Sans; Bernard Charbonnier; Hélène Eltchaninoff; Pascal Guéret; Khalife Khalife; Philippe Asseman; Jacques Puel; Patrick Goldstein; Jean-Pierre Cambou; Tabassome Simon Journal: Circulation Date: 2008-06-30 Impact factor: 29.690
Authors: G Hanania; J-P Cambou; P Guéret; L Vaur; D Blanchard; J-M Lablanche; Y Boutalbi; R Humbert; P Clerson; N Genès; N Danchin Journal: Heart Date: 2004-12 Impact factor: 5.994
Authors: Héctor Bueno; Xavier Rossello; Stuart Pocock; Frans Van de Werf; Chee Tang Chin; Nicolas Danchin; Stephen W-L Lee; Jesús Medina; Ana Vega; Yong Huo Journal: Clin Res Cardiol Date: 2018-04-16 Impact factor: 5.460
Authors: Lihua Zhang; Nihar R Desai; Jing Li; Shuang Hu; Qing Wang; Xi Li; Frederick A Masoudi; John A Spertus; Sudhakar V Nuti; Sisi Wang; Harlan M Krumholz; Lixin Jiang Journal: J Am Heart Assoc Date: 2015-07-10 Impact factor: 5.501
Authors: Yan Gao; Frederick A Masoudi; Shuang Hu; Jing Li; Haibo Zhang; Xi Li; Nihar R Desai; Harlan M Krumholz; Lixin Jiang Journal: J Am Heart Assoc Date: 2014-10-10 Impact factor: 5.501
Authors: Lieven Annemans; Nicolas Danchin; Frans Van de Werf; Stuart Pocock; Muriel Licour; Jesús Medina; Héctor Bueno Journal: Open Heart Date: 2016-02-24
Authors: Aet Saar; Toomas Marandi; Tiia Ainla; Krista Fischer; Mai Blöndal; Jaan Eha Journal: BMC Cardiovasc Disord Date: 2015-10-26 Impact factor: 2.298